Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature

We report the case of a 65-year-old woman, diagnosed with a breast cancer human epidermal growth factor receptor (HER2) previously negative, who developed leptomeningeal carcinomatosis and was treated with intrathecal (IT) trastuzumab (TST). After five doses of IT trastuzumab, at escalading doses, o...

Full description

Saved in:
Bibliographic Details
Main Authors: Cristina Dumitrescu, Dominique Lossignol
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2013/154674
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548985525501952
author Cristina Dumitrescu
Dominique Lossignol
author_facet Cristina Dumitrescu
Dominique Lossignol
author_sort Cristina Dumitrescu
collection DOAJ
description We report the case of a 65-year-old woman, diagnosed with a breast cancer human epidermal growth factor receptor (HER2) previously negative, who developed leptomeningeal carcinomatosis and was treated with intrathecal (IT) trastuzumab (TST). After five doses of IT trastuzumab, at escalading doses, once weekly, the patient's neurological status stabilised, and that result was maintained for two months. There is evidence in the literature that breast cancer receptor status may change over time, and when it occurs, it may modify the therapeutical approach. We reviewed the pertinent literature and concluded that IT trastuzumab might be a promising treatment for patients with HER2-positive breast cancer leptomeningeal carcinomatosis.
format Article
id doaj-art-ebedafd34ba74cc382e323c9c3944588
institution Kabale University
issn 2090-6706
2090-6714
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Case Reports in Oncological Medicine
spelling doaj-art-ebedafd34ba74cc382e323c9c39445882025-02-03T06:12:34ZengWileyCase Reports in Oncological Medicine2090-67062090-67142013-01-01201310.1155/2013/154674154674Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the LiteratureCristina Dumitrescu0Dominique Lossignol1 Department of Medical Oncology, Jules Bordet Institute, Boulevard de Waterloo, 121, 1000 Brussels, BelgiumSupportive Care Unit, Jules Bordet Institute, Boulevard de Waterloo, 121, 1000 Brussels, BelgiumWe report the case of a 65-year-old woman, diagnosed with a breast cancer human epidermal growth factor receptor (HER2) previously negative, who developed leptomeningeal carcinomatosis and was treated with intrathecal (IT) trastuzumab (TST). After five doses of IT trastuzumab, at escalading doses, once weekly, the patient's neurological status stabilised, and that result was maintained for two months. There is evidence in the literature that breast cancer receptor status may change over time, and when it occurs, it may modify the therapeutical approach. We reviewed the pertinent literature and concluded that IT trastuzumab might be a promising treatment for patients with HER2-positive breast cancer leptomeningeal carcinomatosis.http://dx.doi.org/10.1155/2013/154674
spellingShingle Cristina Dumitrescu
Dominique Lossignol
Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature
Case Reports in Oncological Medicine
title Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature
title_full Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature
title_fullStr Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature
title_full_unstemmed Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature
title_short Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature
title_sort intrathecal trastuzumab treatment of the neoplastic meningitis due to breast cancer a case report and review of the literature
url http://dx.doi.org/10.1155/2013/154674
work_keys_str_mv AT cristinadumitrescu intrathecaltrastuzumabtreatmentoftheneoplasticmeningitisduetobreastcanceracasereportandreviewoftheliterature
AT dominiquelossignol intrathecaltrastuzumabtreatmentoftheneoplasticmeningitisduetobreastcanceracasereportandreviewoftheliterature